Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

Deniz Baris

首页> 外文期刊>Current medical research and opinion >Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

【24h】

Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

机译：回复：Hutchinson M，Fox RJ，Havrdova E等。 BG-12（富马酸二甲酯）和其他疾病缓解疗法对复发缓解型多发性硬化症的疗效和安全性：系统评价和混合治疗比较。 Curr Med Res Opin 2014; 30：613-27

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Current medical research and opinion》 |2015年第1期|共3页
作者
Deniz Baris;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献

1. Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27 [J] . Deniz Baris Current medical research and opinion . 2015,第1期

机译：回复：Hutchinson M，Fox RJ，Havrdova E等。 BG-12（富马酸二甲酯）和其他疾病缓解疗法对复发缓解型多发性硬化症的疗效和安全性：系统评价和混合治疗比较。 Curr Med Res Opin 2014; 30：613-27
2. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. [J] . Michael Hutchinson, Robert J Fox, Eva Havrdova, Current medical research and opinion . 2014,第4期

机译：BG-12（富马酸二甲酯）和其他缓解疾病的疗法治疗复发性多发性硬化症的疗效和安全性：系统评价和混合治疗比较。
3. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. [J] . Michael Hutchinson, Robert J Fox, Eva Havrdova, Current medical research and opinion . 2014,第4期

机译：BG-12（富马酸二甲酯）和其他疾病改性治疗的疗效和安全性用于治疗重复多发性硬化剂：系统评价和混合治疗比较。
4. The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review andMeta-Analysis [O] . Paweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, 2014

机译：富马酸二甲酯单药治疗复发型多发性硬化症的疗效：系统评价和荟萃分析
5. Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66 [O] . Jaykaran Charan 2015

机译：Re：Pareek A，Chandurkar N，Thomas N等人。羟基氯喹对2型糖尿病治疗中的疗效和安全性：双盲，与吡格列酮的随机对比。 Curr Med Res Opile 2014; 30：1257-66

Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

著录项

相似文献

相关主题

期刊订阅